Metadon Ep Extractumpharma (Methadone Hydrochloride)

Methadone is a full agonist at the mu‑opioid receptor, which mimics the action of natural endorphins to produce analgesia and reduce cravings. It also blocks NMDA receptors and inhibits the reuptake of serotonin and norepinephrine, contributing to its effectiveness in both pain control and opioid withdrawal suppression.

The dose of methadone is individualized. A qualified prescriber determines the appropriate starting dose, titration schedule, and maintenance dose based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosage adjustments are made under medical supervision.

Safety data for methadone in pregnancy and lactation are limited. Methadone may be used when the benefits outweigh potential risks, but it should be prescribed by a specialist familiar with opioid dependence in pregnant or nursing women. Breastfeeding mothers should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Methadone is a long‑acting synthetic opioid with a well‑established efficacy profile. Compared with buprenorphine, methadone provides full mu‑receptor agonism, which can be advantageous for patients with high opioid tolerance, but it requires more stringent monitoring due to a higher risk of respiratory depression and cardiac effects.

Metadon EP Extractumpharma should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

The product is intended for oral administration. Patients should swallow the tablet or capsule whole with water, unless otherwise directed by a healthcare professional. Doses are taken at the same time each day to maintain stable plasma concentrations.

The most serious risks include respiratory depression, especially after dose escalation or when combined with other CNS depressants, and QT‑interval prolongation that can lead to life‑threatening arrhythmias. Regular monitoring of respiratory function and cardiac ECG is essential to mitigate these risks.

Methadone is contraindicated in patients with known hypersensitivity to methadone, those taking monoamine oxidase inhibitors, and individuals with severe uncontrolled cardiac arrhythmias or significant respiratory compromise. Caution is also advised for patients with severe hepatic impairment or a history of substance misuse without proper supervision.